New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation

Por Barritt, A. Sidney, Darling, Jama M., Hayashi, Paul H.
Publicado em 2011

A blood-borne antigen induces rapid T–B cell contact: a potential mechanism for tolerance induction

Por Gütgemann, Ines, Darling, Jama M, Greenberg, Harry B, Davis, Mark M, Chien, Yueh-Hsiu
Publicado em 2002

High MIG (CXCL9) plasma levels favors response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity

Por Johansson, Susanne, Talloen, Willem, Tuefferd, Marianne, Darling, Jama, Fanning, Gregory, Fried, Michael W., Aerssens, Jeroen
Publicado no Liver Int (2015)

Plasma levels of growth-related oncogene (CXCL1-3) associate with fibrosis and platelet counts in HCV-infected patients

Por Johansson, Susanne, Talloen, Willem, Tuefferd, Marianne, Darling, Jama M, Scholliers, Annick, Fanning, Gregory, Fried, Michael W, Aerssens, Jeroen
Publicado no Aliment Pharmacol Ther (2015)

Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies

Por Ku, Nam-On, Darling, Jama M., Krams, Sheri M., Esquivel, Carlos O., Keeffe, Emmet B., Sibley, Richard K., Lee, Young Moo, Wright, Teresa L., Omary, M. Bishr
Publicado em 2003

α(4)β(7) independent pathway for CD8(+) T cell–mediated intestinal immunity to rotavirus

Por Kuklin, Nelly A., Rott, Lusijah, Darling, Jama, Campbell, James J., Franco, Manuel, Feng, Ningguo, Müller, Werner, Wagner, Norbert, Altman, John, Butcher, Eugene C., Greenberg, Harry B.
Publicado em 2000

Quantitation of Pretreatment Serum IP-10 Improves the Predictive Value of an IL28B Gene Polymorphism for Hepatitis C Treatment Response

Por Darling, Jama M., Aerssens, Jeroen, Fanning, Gregory, McHutchison, John G., Goldstein, David B., Thompson, Alexander J., Shianna, Kevin V., Afdhal, Nezam H., Hudson, Michael L., Howell, Charles D., Talloen, Willem, Bollekens, Jacques, De Wit, Mieke, Scholliers, Annick, Fried, Michael W.
Publicado em 2011

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study

Por Welzel, Tania M, Nelson, David R, Morelli, Giuseppe, Di Bisceglie, Adrian, Reddy, Rajender K, Kuo, Alexander, Lim, Joseph K, Darling, Jama, Pockros, Paul, Galati, Joseph S, Frazier, Lynn M, Alqahtani, Saleh, Sulkowski, Mark S, Vainorius, Monika, Akushevich, Lucy, Fried, Michael W, Zeuzem, Stefan
Publicado no Gut (2017)